AgeX Therapeutics, Inc. (AGE)

Cost of Revenue

$0.00

TTM · Period ending: · USD

AGE logo

AGE Cost of Revenue

Latest reported$0.00
AGE TTM Cost of Revenue ($446.00K → $0.00)
High-resolution chart · PNG

AGE cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AgeX Therapeutics, Inc. Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
0
0
0
67,000
67,000
67,000
67,000
34,000
67,000
72,000
73,000
40,000
12,000
13,000
13,000
13,000
10,000
17,000
19,000
56,000
104,000
127,000
158,000
199,000
198,000
215,000
244,000
345,000
374,000
400,000
446,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.